Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
The aim of this study was to determine if there are significant differences in curvature of the treated vessel after the deployment of a polymeric BRS or MPS in long lesions. The impact of long polymeric bioresorbable scaffolds (BRS) compared with metallic platform stents (MPS) on vessel curvature is unknown. This retrospective study compares 32 patients who received a single everolimus-eluting BRS with 32 patients treated with a single MPS of 28 mm. Quantitative coronary angiography (QCA) was used to evaluate curvature of the treatment and peri-treatment region before and after percutaneous coronary intervention (PCI). Baseline demographic and angiographic characteristics were similar between the BRS and MPS groups. Pretreatment lesion length was 22.19 versus 20.38 mm in the BRS and MPS groups respectively (p = 0.803). After treatment, there was a decrease in median diastolic curvature in the MPS group (from 0.257 to 0.199 cm−1, p = 0.001). A similar trend was observed in the BRS group but did not reach statistical significance (median diastolic curvature from 0.305 to 0.283 cm−1, p = 0.056). Median Percentage relative change in diastolic curvature was lower in the BRS group compared with the MPS group (BRS vs. MPS: 7.48 vs. 29.4%, p = 0.013). By univariate analysis, use of MPS was an independent predictor of change in diastolic curvature (p = 0.022). In the deployment of long coronary scaffolds/stents (28 mm in length), BRS provides better conformability compared with MPS.
|Keywords||Bioresorbable scaffolds, Conformability, Drug eluting stents, Long coronary lesions, Metallic platform stents, Percutaneous coronary Intervention|
|Persistent URL||dx.doi.org/10.1007/s10554-017-1193-0, hdl.handle.net/1765/108150|
|Journal||International Journal of Cardiovascular Imaging|
Fam, J.M, Ishibashi, Y, Felix, C.M, Zhang, B.-C, Diletti, R, van Mieghem, N.M, … van Geuns, R.J.M. (2017). Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions. International Journal of Cardiovascular Imaging, 33(12), 1863–1871. doi:10.1007/s10554-017-1193-0